Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors

Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors

US Patent 9346813 · Granted May 24, 2016

Estimated economic value: $172,702,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matriptase 2 inhibitors and uses thereof2025
Substituted heterocyclyl derivatives as CDK inhibitors2025
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
Modulators of the integrated stress pathway2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Anti-EGFR antibody-drug conjugates2023
Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK 2021
Substituted heterocyclyl derivatives as CDK inhibitors2021
Prodrug modulators of the integrated stress pathway2021